Literature DB >> 1707239

Cellular events associated with inflammatory angiogenesis in the mouse cornea.

C Sunderkötter1, W Beil, J Roth, C Sorg.   

Abstract

The aim of this study was to establish an angiogenesis model in the mouse and to define immunohistochemically the cellular events that precede angiogenesis. After chemical cauterization of the murine cornea, neovascularization was observed within 36 hours. The cellular infiltrate was analyzed by using antibodies on cryostat and paraffin sections and by histochemical staining for mast cells. It was found that neither T lymphocytes nor mast cells nor macrophages in a more mature stage of development were part of the infiltrate that preceded the ingrowth of new blood vessels. Instead, the infiltrating cells appearing from 3 hours on were granulocytes and inflammatory monocytes, as detected by an antibody against the calcium-binding protein MRP14. The authors conclude that the induction of angiogenesis during nonspecific inflammation is associated with the early influx of myelomonocytic cells, but not with the infiltration of mature macrophages, T lymphocytes, or mast cells. This study shows that immunohistochemical analysis of cauterized murine corneas presents a useful tool for further studies on cells and cell products involved in the angiogenic process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707239      PMCID: PMC1886108     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization.

Authors:  C H Fromer; G K Klintworth
Journal:  Am J Pathol       Date:  1975-06       Impact factor: 4.307

2.  An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. III. Studies related to the vasoproliferative capability of polymorphonuclear leukocytes and lymphocytes.

Authors:  C H Fromer; G K Klintworth
Journal:  Am J Pathol       Date:  1976-01       Impact factor: 4.307

3.  Induction of neovascularization by activated human monocytes.

Authors:  A E Koch; P J Polverini; S J Leibovich
Journal:  J Leukoc Biol       Date:  1986-02       Impact factor: 4.962

4.  Fibrin degradation and angiogenesis: quantitative analysis of the angiogenic response in the chick chorioallantoic membrane.

Authors:  W D Thompson; R Campbell; T Evans
Journal:  J Pathol       Date:  1985-01       Impact factor: 7.996

5.  Mast cells are present during angiogenesis in the chick extraembryonic vascular system.

Authors:  D J Wilson
Journal:  Experientia       Date:  1985-02-15

Review 6.  How does extracellular matrix control capillary morphogenesis?

Authors:  D E Ingber; J Folkman
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

Review 7.  Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta.

Authors:  A B Roberts; M B Sporn
Journal:  Am Rev Respir Dis       Date:  1989-10

8.  Mast cells in corneal immune reaction.

Authors:  S S Smith; P K Basu
Journal:  Can J Ophthalmol       Date:  1970-04       Impact factor: 1.882

9.  An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. II. Studies on the effect of leukocytic elimination on corneal vascularization.

Authors:  C H Fromer; G K Klintworth
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

10.  Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.

Authors:  Y A Sidky; R Auerbach
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  13 in total

1.  Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles.

Authors:  Mirela Anghelina; Padma Krishnan; Leni Moldovan; Nicanor I Moldovan
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 2.  Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved.

Authors:  Maria Lúcia Zaidan Dagli; Francisco Javier Hernandez-Blazquez
Journal:  J Membr Biol       Date:  2007-07-25       Impact factor: 1.843

3.  Reaction patterns of pulmonary macrophages in protracted asphyxiation.

Authors:  Theresa Strunk; Dorothee Hamacher; Ronald Schulz; Bernd Brinkmann
Journal:  Int J Legal Med       Date:  2010-02-12       Impact factor: 2.686

4.  Macrophage subtype patterns in protracted asphyxiation.

Authors:  A Du Chesne; R Cecchi-Mureani; K Püschel; B Brinkmann
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

Review 5.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

6.  Expression of the calcium-binding proteins MRP8 and MRP14 in monocytes is regulated by a calcium-induced suppressor mechanism.

Authors:  J Roth; M Goebeler; V Wrocklage; C van den Bos; C Sorg
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

7.  S100A proteins in the pathogenesis of experimental corneal neovascularization.

Authors:  Changyou Li; Feng Zhang; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-10-31       Impact factor: 2.367

8.  Interleukin-8. A corneal factor that induces neovascularization.

Authors:  R M Strieter; S L Kunkel; V M Elner; C L Martonyi; A E Koch; P J Polverini; S G Elner
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

9.  MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization.

Authors:  Ce Zhang; Yonggang Liu; Jonathan Gilthorpe; Johan R C van der Maarel
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

Review 10.  Therapeutic angiogenesis in cardiovascular disease.

Authors:  Hilal Al Sabti
Journal:  J Cardiothorac Surg       Date:  2007-11-16       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.